Neuroone Medical Technologies annual revenue
2010
2011
2012
2013
2014
2015
2016
2021
2022
2023
2024
2025
Neuroone Medical Technologies Revenue Growth & History (NMTC)
Neuroone Medical Technologies reported $9.1M in revenue for fiscal 2025, an increase of 163.47% from the previous fiscal year.
View full Neuroone Medical Technologies company overviewNeuroone Medical Technologies annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $9.1M | $5.6M | +163.47% |
| 2024 | 2024-09-30 | $3.5M | $1.5M | +76.86% |
| 2023 | 2023-09-30 | $2.0M | $1.8M | +1040.65% |
| 2022 | 2022-09-30 | $171,169 | −$6,977 | −3.92% |
| 2021 | 2021-09-30 | $178,146 | — | — |
| 2016 | 2016-12-31 | $0 | $0 | — |
| 2015 | 2015-12-31 | $0 | −$773 | −100.00% |
| 2014 | 2014-12-31 | $773 | −$476 | −38.11% |
| 2013 | 2013-12-31 | $1,249 | $328 | +35.61% |
| 2012 | 2012-12-31 | $921 | −$4,477 | −82.94% |
| 2011 | 2011-12-31 | $5,398 | $4,231 | +362.55% |
| 2010 | 2010-12-31 | $1,167 | — | — |
Neuroone Medical Technologies quarterly revenue
Q1.11
Q3.11
Q1.12
Q3.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $2.0M | $277,055 | +16.34% |
| Q2 2026 | 2026-03-31 | $1.9M | $475,500 | +34.29% |
| Q1 2026 | 2025-12-31 | $2.9M | −$381,532 | −11.65% |
| Q4 2025 | 2025-09-30 | $2.7M | $2.5M | +906.64% |
| Q3 2025 | 2025-06-30 | $1.7M | $870,274 | +105.39% |
| Q2 2025 | 2025-03-31 | $1.4M | $9,256 | +0.67% |
| Q1 2025 | 2024-12-31 | $3.3M | $2.3M | +234.90% |
| Q4 2024 | 2024-09-30 | $272,284 | −$469,496 | −63.29% |
| Q3 2024 | 2024-06-30 | $825,776 | $195,870 | +31.10% |
| Q2 2024 | 2024-03-31 | $1.4M | $911,118 | +195.45% |
| Q1 2024 | 2023-12-31 | $977,649 | $863,070 | +753.25% |
| Q4 2023 | 2023-09-30 | $741,780 | $672,992 | +978.36% |
| Q3 2023 | 2023-06-30 | $629,906 | $597,857 | +1865.45% |
| Q2 2023 | 2023-03-31 | $466,176 | $429,592 | +1174.26% |
| Q1 2023 | 2022-12-31 | $114,579 | $80,831 | +239.51% |
| Q4 2022 | 2022-09-30 | $68,788 | $20,452 | +42.31% |
| Q3 2022 | 2022-06-30 | $32,049 | −$8,047 | −20.07% |
| Q2 2022 | 2022-03-31 | $36,584 | $18,344 | +100.57% |
| Q1 2022 | 2021-12-31 | $33,748 | −$37,726 | −52.78% |
| Q4 2021 | 2021-09-30 | $48,336 | — | — |
| Q3 2021 | 2021-06-30 | $40,096 | — | — |
| Q2 2021 | 2021-03-31 | $18,240 | — | — |
| Q1 2021 | 2020-12-31 | $71,474 | — | — |
| Q2 2017 | 2017-06-30 | $0 | $0 | — |
| Q1 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-12-31 | $0 | $113 | +100.00% |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $0 | $0 | — |
| Q1 2016 | 2016-03-31 | $0 | −$113 | −100.00% |
| Q4 2015 | 2015-12-31 | −$113 | −$279 | −168.07% |
| Q3 2015 | 2015-09-30 | $0 | −$139 | −100.00% |
| Q2 2015 | 2015-06-30 | $0 | −$303 | −100.00% |
| Q1 2015 | 2015-03-31 | $113 | −$52 | −31.52% |
| Q4 2014 | 2014-12-31 | $166 | $26 | +18.57% |
| Q3 2014 | 2014-09-30 | $139 | −$113 | −44.84% |
| Q2 2014 | 2014-06-30 | $303 | −$148 | −32.82% |
| Q1 2014 | 2014-03-31 | $165 | −$241 | −59.36% |
| Q4 2013 | 2013-12-31 | $140 | — | — |
| Q3 2013 | 2013-09-30 | $252 | $229 | +995.65% |
| Q2 2013 | 2013-06-30 | $451 | — | — |
| Q1 2013 | 2013-03-31 | $406 | $259 | +176.19% |
| Q3 2012 | 2012-09-30 | $23 | −$789 | −97.17% |
| Q1 2012 | 2012-03-31 | $147 | −$2,924 | −95.21% |
| Q3 2011 | 2011-09-30 | $812 | — | — |
| Q1 2011 | 2011-03-31 | $3,071 | — | — |
Neuroone Medical Technologies revenue growth trends
Neuroone Medical Technologies's latest reported quarter, Q3 2026, generated $2.0M in revenue, an increase of 16.34% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Neuroone Medical Technologies source filings ↗